Meloxicam
- Product NDC
- 53225-3075
- 11-digit product format
- 532253075
- Labeler code
- 53225
- Product ID
- 53225-3075_42f45cbf-49c5-8971-e063-6394a90a291d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meloxicam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Terrain Pharmaceuticals, Inc.
- Application
- ANDA077882
- Marketing category
- ANDA
- Marketing start
- 2025-10-20
- Substance
- MELOXICAM
- Active strength
- 7.5 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077882-001 | MELOXICAM | MELOXICAM | 7.5MG | TABLET / ORAL | AB | 2006-07-20 | |
| A077882-002 | MELOXICAM | MELOXICAM | 15MG | TABLET / ORAL | AB | 2006-07-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077882-001 | AB |
| A077882-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077882-001 | MELOXICAM | 7.5MG | TABLET / ORAL | AB | 2006-07-20 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077882-002 | MELOXICAM | 15MG | TABLET / ORAL | AB | 2006-07-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077882-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077882-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 5488ccc1-e416-e5d7-e063-6294a90a6cb8 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ec3b7-2b6d-cd9e-e063-6394a90a78ff | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ef3ed-ab67-ec85-e063-6294a90ab1da | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Terrain Pharmaceuticals, Inc. | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 53225-3075 |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 7895f389-1509-4e03-8668-526ab1627fc8 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 453c5328-090e-0159-e063-6394a90a06b7 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meloxicam
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MELOXICAM | 7.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| VG2QF83CGL | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53225-3075-1 | Meloxicam | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 53225-3075-2 | Meloxicam | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 53225-3075-3 | Meloxicam | 90 in 1 BOTTLE | TABLET | 90 | 2 | |
| 53225-3075-4 | Meloxicam | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 53225-3075-5 | Meloxicam | 120 in 1 BOTTLE | TABLET | 120 | 2 | |
| 53225-3075-6 | Meloxicam | 500 in 1 BOTTLE | TABLET | 500 | 2 | |
| 53225-3075-7 | Meloxicam | 1000 in 1 BOTTLE | TABLET | 1000 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53225-3075-1 | EA - Each | 53225-3075 | 9f34ef86-c2f9-453c-91e5-0750acf4303f | 1 | 2026-01-08 |
| 53225-3075-2 | EA - Each | 53225-3075 | 5741ecf4-ea23-4687-8de0-2269971bc935 | 1 | 2026-01-08 |
| 53225-3075-3 | EA - Each | 53225-3075 | a1a9b350-85db-4c79-9425-4f6f48d0a8b9 | 1 | 2026-01-08 |
| 53225-3075-4 | EA - Each | 53225-3075 | ad0b0d72-8db3-4dc6-9831-b41644cfa203 | 1 | 2026-01-08 |
| 53225-3075-5 | EA - Each | 53225-3075 | b26a7365-1b95-4588-912b-b03b76354991 | 1 | 2026-01-08 |
| 53225-3075-6 | EA - Each | 53225-3075 | d8c17720-2c29-48fc-9a47-8eeb4dbd0029 | 1 | 2026-01-08 |
| 53225-3075-7 | EA - Each | 53225-3075 | 163c63ea-c314-47dd-a560-30eacc5cf438 | 1 | 2026-01-08 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 152695 | meloxicam 15 MG Oral Tablet | PSN | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2 |
| 152695 | meloxicam 15 MG Oral Tablet | SCD | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | 453c5328-090e-0159-e063-6394a90a06b7 | 1 |
| 311486 | meloxicam 7.5 MG Oral Tablet | PSN | 7895f389-1509-4e03-8668-526ab1627fc8 | 1 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | 453c5328-090e-0159-e063-6394a90a06b7 | 1 |
| 311486 | meloxicam 7.5 MG Oral Tablet | SCD | 7895f389-1509-4e03-8668-526ab1627fc8 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 53225-3075-1 | 53225307501 | 30 TABLET in 1 BOTTLE (53225-3075-1) | 30 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-2 | 53225307502 | 60 TABLET in 1 BOTTLE (53225-3075-2) | 60 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-3 | 53225307503 | 90 TABLET in 1 BOTTLE (53225-3075-3) | 90 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-4 | 53225307504 | 100 TABLET in 1 BOTTLE (53225-3075-4) | 100 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-5 | 53225307505 | 120 TABLET in 1 BOTTLE (53225-3075-5) | 120 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-6 | 53225307506 | 500 TABLET in 1 BOTTLE (53225-3075-6) | 500 tablet | 2025-10-20 | No | No | Current |
| 53225-3075-7 | 53225307507 | 1000 TABLET in 1 BOTTLE (53225-3075-7) | 1000 tablet | 2025-10-20 | No | No | Current |